Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Molecular Biology|January 4, 2017
Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon ResonanceNicole Willemsen-Seegers, Joost C M Uitdehaag, Martine B W Prinsen, et al.Bioorganic & Medicinal Chemistry|January 9, 2003
Synthesis and structure-activity relationships of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids as HB-EGF shedding inhibitorsKazuya Yoshiizumi, Minoru Yamamoto, Tomohiro Miyasaka, et al.Clinical and Translational Science|November 11, 2024
Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I studyKyoko Miyamoto, Robert M Miller, Christine Voors-Pette, et al.British Journal of Cancer|November 27, 2020
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846Teppei Sugano, Mari Masuda, Fumitaka Takeshita, et al.Cancers|May 21, 2020
Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial SarcomaTetsuya Sekita, Tesshi Yamada, Eisuke Kobayashi, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 20, 2023
BCL6B Contributes to Ocular Vascular Diseases via Notch Signal SilencingMiruto Tanaka, Shinsuke Nakamura, Tomohisa Sakaue, et al.Journal of Medicinal Chemistry|February 8, 2002
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acidsMasaaki Sawa, Takao Kiyoi, Kiriko Kurokawa, et al.Nature Communications|January 11, 2024
Single-molecule localization microscopy reveals STING clustering at the trans-Golgi network through palmitoylation-dependent accumulation of cholesterolHaruka Kemmoku, Kanoko Takahashi, Kojiro Mukai, et al.JCI Insight|January 5, 2021
Direct conversion of osteosarcoma to adipocytes by targeting TNIKToru Hirozane, Mari Masuda, Teppei Sugano, et al.Blood Cancer Journal|May 7, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigationsNatalia Timofeeva, Breana Herrera, Hitomi Fujiwara, et al.Pageof 7